Chris Arington News Today

/PRNewswire/ -- Prasco Laboratories announced today the launch of the Authorized Generic of ZIOPTAN® (tafluprost ophthalmic solution) 0.0015%. This is Prascos...

(1) NORTHVALE, NJ / ACCESSWIRE / May 4, 2021 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) announced today that its distribution and marketing partner Prasco, LLC ("Prasco"), has launched Elites generic Loxapine capsules. Elite entered a license, supply, and distribution agreement ("Agreement") with Prasco for Elites Abbreviated New Drug Application (ANDA) for Loxapine Succinate capsules, 5 mg, 10 mg, 25 mg, and 50 mg ("Loxapine Capsules"). Loxapine is indicated for the ...

Elite Pharmaceuticals Enters into an Exclusive Distribution Agreement with Prasco, LLC and Announces Commercial Launch of Loxapine Capsules ACCESSWIRE 05 May 2021, 00:31 GMT+10 NORTHVALE, NJ / ACCESSWIRE / May 4, 2021 / Elite Pharmaceuticals, Inc. (Elite or the Company) (OTCBB:ELTP) announced today that its distribution and marketing partner Prasco, LLC (Prasco), has launched Elites generic Loxapine capsules. Elite entered a license, supply, and distribution agreement (Agreement) with Prasco fo...